Pentagon awards blood technology contract to Terumo BCT

10/24/2013 | American City Business Journals

Terumo BCT has secured a Defense Department contract worth up to $29.9 million to improve its pathogen reduction technologies. Funding will help the company seek FDA approval of its Mirasol system and support testing and clinical trials. Terumo BCT will collaborate with the Army Medical Research and Material Command.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC